Alivus Life Sciences Ltd (ALIVUS)

NSE · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

₹1,415.30

As of 30 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close ₹1,415.30 on 30 Oct 2026. The share price traded between ₹819.00 and ₹1,493.80 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close ₹1,415.30

Low ₹819.00High ₹1,493.80

Market cap₹17,691 crorelast close × shares
P/E28.8on reported profit, last four quarters
Net profit₹603 crlast 12 months
Return on equity17.9%year to Mar 2026
EBITDA margin31%year to Mar 2026
Debt to equity0.02year to Mar 2026
Net margin22.1%year to Mar 2026
Dividend yield0.36%last 12 months

Price trend

Revenue and profit

RevenueNet profit₹ crore
01,0002,0003,000
YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue2,1232,1612,2832,3872,552
Net profit419467471486564
EBITDA margin29%30%30%29%31%
Borrowings319175757

₹ crore. Over three years, compounded: revenue grew 5.7% a year, net profit grew 6.5% a year.

Recent filings

Questions about Alivus Life Sciences Ltd

What is Alivus Life Sciences Ltd's market value?

Alivus Life Sciences Ltd's market value is ₹17,691 crore as of 30 Oct 2026 close: the last close times the shares in issue. Its P/E is 28.8, the last close over earnings per share for the last four reported quarters.

Who are Alivus Life Sciences Ltd's largest named shareholders?

In the shareholding pattern for the quarter ended 30 Sep 2026, the largest named holders above 1% were: Nirma Limited (promoter group) 74.85%; Quant Mutual Fund - Quant Small Cap Fund (public) 2.85%; Government Pension Fund Global (public) 2.33%. Percentages are of all shares.

Go further with ALIVUS

Free to start: test a trading idea on ALIVUS's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceuticals), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.